IP Library Granted Patent US 10,045,925
Granted Patent B2
US 10,045,925 · App. 14/931,744 · Granted Aug 14, 2018

Skincare formulations and regimens

Inventor: Christin Powell (San Bruno, CA)
Assignee: STELLA & DOT LLC
A61K8/4953A61K8/27A61K8/29A61K8/347A61K8/361A61K8/4946A61K8/64A61K8/735A61K8/97A61Q19/08A61Q17/04A61Q19/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,045,925
App. No.
14/931,744
Granted
Aug 14, 2018
Kind
B2
Abstract

Provided are compositions, comprising a neolignan, ectoin, and a molecule of Formula I: wherein R 1 , R 2 and R 3 are independently H, methyl, ethyl, propyl, or isopropyl; wherein X is S or O. In some cases, the molecule of Formula I is ergothioneine (EGT). In some cases, the at least one neolignan is honokiol or a derivative thereof. Honokiol may be provided in the form of magnolia bark extract. Methods of making and using these compositions are also provided.

Claims (48)

1. A composition comprising:

at least one neolignan;

ectoin; and

a molecule of Formula I:

wherein R 1 , R 2 and R 3 are independently H, methyl, ethyl, propyl, or isopropyl;

wherein X is S or O;

wherein said composition when contacted with a skin cell in a predetermined amount for a predetermined period of time results in a reduction of at least one symptom of skin aging.

2. The composition of claim 1 , wherein said at least one neolignan is honokiol provided in the form of magnolia bark extract or a derivative thereof.

3. The composition of claim 1 , further comprising at least one ultraviolet spectrum attenuating agent comprising zinc oxide, titanium dioxide, derivatives or combinations thereof, in an amount sufficient to reduce the exposure of said skin cell from ultraviolet radiation as compared to an otherwise identical composition not comprising said ultraviolet spectrum attenuating agent.

4. The composition of claim 3 , comprising from about 1% w/w to about 20% w/w zinc oxide and from about 0.5% w/w to about 20% w/w titanium dioxide based on the total weight of the composition.

5. The composition of claim 1 , further comprising at least one polypeptide, derivative or fragment thereof; or protein, derivative or fragment thereof.

6. The composition of claim 5 , comprising at least one polypeptide, wherein said at least one polypeptide comprises the sequence: Tyr-D-Ala-Gly-Phe-Leu.

7. The composition of claim 5 , comprising at least one polypeptide, wherein said at least one polypeptide comprises the sequence Glu-Glu-Met-Gln-Arg-Arg (SEQ ID NO: 1).

8. The composition of claim 5 , comprising a palmitic acid conjugate of a polypeptide comprising the sequence Gly-Gln-Pro-Arg (SEQ ID NO: 2).

9. The composition of claim 5 , comprising at least one polypeptide, wherein said at least one polypeptide comprises the sequence beta-Ala-His-Ser-His (SEQ ID NO: 3), or a derivative thereof.

10. The composition of claim 1 , further comprising:

a first polypeptide comprising the sequence Tyr-D-Ala-Gly-Phe-Leu (Pentapeptide-18) or a derivative thereof;

a second polypeptide comprising the sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-CONH 2 (Acetyl Hexapeptide-8) (SEQ ID NO: 4) or a derivative thereof;

a third polypeptide which is a palmitic acid conjugate of a polypeptide comprising the sequence Gly-Gln-Pro-Arg (Palmitoyl Tetrapeptide-7) (SEQ ID NO: 2) or a derivative thereof; and

a fourth polypeptide comprising the sequence Ac-beta-Ala-His-Ser-His (Acetyl Tetrapeptide-5) (SEQ ID NO: 5) or a derivative thereof.

11. The composition of claim 1 , wherein said reduction of at least one symptom of skin aging is selected from the group consisting of:

an improvement in the appearance of skin hyperpigmentation;

a reduction in the appearance of crow's feet;

an improvement in the elasticity of the skin;

an improvement in the firmness or texture of the skin; and

a reduction in the appearance of redness of the skin.

12. The composition of claim 1 , wherein said predetermined period of time is from about one day to about 24 weeks.

13. The composition of claim 1 , comprising about 0.01% w/w-25% w/w neolignan, 0.1% w/w-70% w/w molecule of Formula I, and 0.1 w/w-25% w/w ectoin based on the total weight of the composition.

14. A composition, comprising

ergothioneine;

honokiol;

ectoin;

a first polypeptide comprising the sequence Tyr-D-Ala-Gly-Phe-Leu (Pentapeptide-18) or a derivative thereof;

a second polypeptide comprising the sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-CONH 2 (Acetyl Hexapeptide-8) (SEQ ID NO: 4) or a derivative thereof;

a third polypeptide which is a palmitic acid conjugate of a polypeptide comprising the sequence Gly-Gln-Pro-Arg (Palmitoyl Tetrapeptide-7) (SEQ ID NO: 2) or a derivative thereof; and

a fourth polypeptide comprising the sequence Ac-beta-Ala-His-Ser-His (Acetyl Tetrapeptide-5) (SEQ ID NO: 5) or a derivative thereof.

15. A method of reducing the depth of visible wrinkles on the skin of a subject comprising contacting the skin of said subject with the composition of claim 14 in an amount and time sufficient for reducing the depth of visible wrinkles on the skin of said subject.

16. A method of making a composition comprising combining:

at least one neolignan;

ectoin;

a molecule of Formula I:

wherein R 1 , R 2 and R 3 are independently H, methyl, ethyl, propyl, or isopropyl; and

wherein X is S or O; and

at least one ingredient selected from the group consisting of: Potassium Azeloyl Diglycinate, Hamamelis Virginiana (Witch Hazel) Extract, Glycerin, Methyl Gluceth-20, Magnolia Officinalis Bark Extract, Pentylene Glycol, Salix Nigra (Willow) Bark Extract, Magnesium Aspartate, Zinc Gluconate, Copper Gluconate, Microcitrus Austraiasica Fruit Extract, Mucor Miehei Extract, Glucosamine HCI, Urea, Phenoxyethanol, Ethylhexylglycerin, Polysorbate 20, Magnolia Glauca Flower Water, Sodium PCA, Potassium Sorbate, Allantoin, Dipotassium Glycyrrhizate, Alcohol Denatured, Disodium EDTA, Lactic Acid, Maltodextrin, Lecithin, Tocopherol, Vitis Vinifera (Grape) Seed Extract, Sodium Hydroxide, Caprylic/Capric Triglyceride, Jasminum Officinale (Jasmine) Extract, Rosa Damascena Flower Oil, Pelargonium Graveolens Oil, Citrus Medica Limonum (Lemon) Peel Oil, Camellia Sinensis Leaf (Green Tea) Extract, Mentha Viridis (Spearmint) Leaf Oil, Juniperus Virginiana Oil, Pentapeptide-18, Acetyl Hexapeptide-8, Caprylyl Methicone, Glycerin, Butylene Glycol, Beta Glucan (Oat), Isosorbide Dicaprylate, Dimethicone, Isostearyl Alcohol, Butylene Glycol Cocoate, Polyacrylate-13, Magnolia Officinalis Bark Extract, Ergothioneine, Ectoin, Palmitoyl Tetrapeptide-7, Acetyl Tetrapeptide-5, Tetrahexyldecyl Ascorbate, Tyrosine, Hesperidin Methyl Chalcone, Tricholoma Matsutake Extract, Corallina Officinalis Extract, Sodium Hyaluronate, Sodium Potassium Aluminum Silicate, Silica, Pullulan, Steareth-20, Dipeptide-2, Ethylcellulose, Polysorbate 20, Polyisobutene, Dimethiconol, Panthenol, Oryza Sativa (Rice) Bran Oil, Lecithin, Allantoin, Xanthan Gum, Elaeis Guineensis Oil, Tocotrienols, Tocopherol, Phenoxyethanol, Maltodextrin, Vitis Vinifera (Grape) Seed Extract, Sodium Phytate, Fragrance, Ethylhexylglycerin, Mica, Titanium Dioxide, Glycerin, Ricinus Communis (Castor) Seed Oil, Cetearyl Olivate, Lecithin, Caprylic/Capric Triglyceride, Sorbitan Olivate, Cetearyl Alcohol, Dimethicone, Ergothioneine, Isosorbide Dicaprylate, Glyceryl Behenate, Ethyl Linoleate, Ethylhexyl Palmitate, Silica Dimethyl Silylate, Butylene Glycol, Sodium Hyaluronate, Magnolia Officinalis Bark Extract, Ectoin, Tetrahexyldecyl Ascorbate, Panthenol, Hydrogenated Castor Oil, Cera Alba, Copernicia Cerifera (Carnauba) Wax, Sodium PCA, Urea, Trehalose, Triacetin, Polyquaternium-51, Methylglucoside Phosphate, Copper Lysinate/Prolinate, Ceteareth-20, Magnesium Aspartate, Zinc Gluconate, Copper Gluconate, C8-22 Alkyl Acrylates/Methacrylic Acid Crosspolymer, Persea Gratissima (Avocado) Oil, Squalane, Oenothera Biennis (Evening Primrose) Oil, Fragrance, Allantoin, Stearyl Glycyrrhetinate, Maltodextrin, Tocopherol, Vitis Vinifera (Grape) Seed Extract, Xanthan Gum, Arginine, Aloe Barbadensis Leaf Juice, Macadamia Ternifolia Seed Oil, Phenoxyethanol, Ethylhexylglycerin, Sodium Phytate, Tricholoma Matsutake Extract, cyclopentasiloxane, C12-15 Alkyl Benzoate, Titanium Dioxide, Zinc Oxide, Dimethicone, Polyglyceryl-3Polydimethylsiloxyethyl Dimethicone, Dimethicone/PEG-10/15 Crosspolymer, Stearic Acid, Aluminum Hydroxide, Sodium Chloride, Glycerin, Magnolia Officinalis Bark Extract, Ectoin, Caprylyl Glycol, Teprenone, Sodium Hyaluronate, Tetrahexyldecyl Ascorbate, Ergothioneine, Tocopheryl Acetate, Tocopherol, Maltodextrin, Lecithin, Ethylhexyl Palmitate, Caprylic/Capric Triglyceride, PEG/PPG-18/18 Dimethicone, Polyglycerin-3 Crosspolymer, Hexyl Laurate, Cyclohexasiloxane, Triethoxysilylethyl Polydimethylsiloxyethyl Hexyl Dimethicone, Dimethicone/Vinyl Dimethicone Crosspolymer, Polyglyceryl-4 Isostearate, Cetyl PEG/PPG-10/1 Dimethicone, Silica Dimethyl Silylate, Triethoxycaprylylsilane, Phenoxyethanol, Ethylhexylglycerin, Butylene Glycol, Hexylene Glycol, Fragrance, Mica and Silica.

17. The method of claim 16 , wherein the composition is in the form of at least one selected from the group consisting of a cream, lotion, serum, gel and moisturizer.

18. A kit comprising the composition of claim 1 , at least one container, and instructions for use.

19. A system comprising at least two kits of claim 18 .

20. The composition of claim 1 , wherein when the composition is stored in a sealed container at 25° C. and the container is placed in an atmosphere having 50% relative humidity and an atmospheric pressure of 1 atmosphere, at least 80% of at least one of neolignan, ectoin, and the molecule of Formula I remains after a period of at least about: 6 months, 1 year, 1.5 years, 2 years, 2.5 years or 3 years.

Assignments (6)
SECURITY INTEREST Recorded Jul 1, 2025
From: FORUM BRANDS HOLDINGS, INC.; FORUM BRANDS, LLC; BRANDABLE TECHNOLOGIES, LLC; FORUM FAMILY PRODUCTS, LLC; FORUM FITNESS HOLDINGS, LLC; FORUM OUTDOOR HOLDINGS, LLC; FORUM HOME & KITCHEN, LLC; FORUM HEALTH & PERSONAL CARE, LLC; FORUM PET PRODUCTS, LLC
To: MIDCAP FUNDING IV TRUST
Reel/Frame 071572/0980 →
SECURITY INTEREST Recorded May 22, 2025
From: FORUM HEALTH & PERSONAL CARE, LLC
To: TRIPLEPOINT VENTURE GROWTH BDC CORP.
Reel/Frame 071203/0355 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER (RATHER THAN "PATENT NUMBER") FOR 10/045,925, AND REMOVE THE RECORDATION FROM "APPLICATION NUMBER" 10/045,925 AND ADD THIS RECORDATION TO US PATENT NUMBER 10,045925 PREVIOUSLY RECORDED AT REEL: 68428 FRAME: 411. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 3, 2024
From: STELLA & DOT LLC; HERRIN, JESSICA
To: FORUM HEALTH & PERSONAL CARE, LLC
Reel/Frame 068923/0592 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2024
From: STELLA & DOT LLC; HERRIN, JESSICA
To: FORUM HEALTH & PERSONAL CARE, LLC
Reel/Frame 068428/0411 →
CHANGE OF ADDRESS Recorded Jun 27, 2016
From: STELLA & DOT LLC
To: STELLA & DOT LLC
Reel/Frame 039173/0270 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2016
From: POWELL, CHRISTIN
To: STELLA & DOT LLC
Reel/Frame 038007/0981 →
Continuity (2)
Provisional Application 62074536 · Nov 3, 2014
Related Publication 20160120781A1 · May 5, 2016